Rare diseases
Investigational molecules
Locations
Back to Hungary58 clinical trials in Eger, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
HungaryA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
HungaryA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
HungaryA study testing duvakitug for patients with moderately to severely active ulcerative colitis
HungaryStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
HungaryStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
HungaryStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
HungarySafety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease
HungaryPhase 3 Study of Romiplostim Combined with Prednisolone versus Prednisolone Alone in Adults with Previously Untreated Primary Immune Thrombocytopenia (ITP)
HungaryLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
HungaryStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
HungaryA study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.
HungaryThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on bladder cancer treatments and innovative therapies for metastatic breast cancer. Studies evaluate new combination treatments and their effectiveness in improving patient outcomes.
Multiple trials investigating targeted treatments for various stages of cancer, including new approaches for KRAS/NRAS mutations.
Comprehensive research into blood-related conditions, including B-cell malignancies and various forms of leukemia. Studies focus on novel therapeutic approaches and combination treatments.
Innovative treatments being evaluated for both newly diagnosed and relapsed/refractory conditions.
Studies addressing various chronic conditions, including osteoarthritis and autoimmune disorders. Research focuses on pain management and improving patient mobility.
Evaluating both conventional and innovative treatment approaches for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
